These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 28594755
1. Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion. Krashin JW, Stuart GS, Garrett J, Spector H, Bryant AG, Charm S, Morse JE. Obstet Gynecol; 2017 Jul; 130(1):109-117. PubMed ID: 28594755 [Abstract] [Full Text] [Related]
2. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion. Steinauer JE, Upadhyay UD, Sokoloff A, Harper CC, Diedrich JT, Drey EA. Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190 [Abstract] [Full Text] [Related]
3. Funding policies and postabortion long-acting reversible contraception: results from a cluster randomized trial. Rocca CH, Thompson KM, Goodman S, Westhoff CL, Harper CC. Am J Obstet Gynecol; 2016 Jun; 214(6):716.e1-8. PubMed ID: 26692178 [Abstract] [Full Text] [Related]
4. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial. Hubacher D, Spector H, Monteith C, Chen PL, Hart C. Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799 [Abstract] [Full Text] [Related]
8. Contraception after medication abortion in the United States: results from a cluster randomized trial. Rocca CH, Goodman S, Grossman D, Cadwallader K, Thompson KMJ, Talmont E, Speidel JJ, Harper CC. Am J Obstet Gynecol; 2018 Jan; 218(1):107.e1-107.e8. PubMed ID: 28986072 [Abstract] [Full Text] [Related]
10. Introduction of postabortion contraception, prioritizing long-acting reversible contraceptives, in the principal maternity hospital of Gabon. Mayi-Tsonga S, Obiang PA, Minkobame U, Ngouafo D, Ambounda N, de Souza MH. Int J Gynaecol Obstet; 2014 Jul; 126 Suppl 1():S45-8. PubMed ID: 24745694 [Abstract] [Full Text] [Related]
11. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial. Hognert H, Kopp Kallner H, Cameron S, Nyrelli C, Jawad I, Heller R, Aronsson A, Lindh I, Benson L, Gemzell-Danielsson K. Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217 [Abstract] [Full Text] [Related]
13. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic. Bahamondes L, Bottura BF, Bahamondes MV, Gonçalves MP, Correia VM, Espejo-Arce X, Sousa MH, Monteiro I, Fernandes A. Hum Reprod; 2014 Oct 10; 29(10):2163-70. PubMed ID: 25085802 [Abstract] [Full Text] [Related]
14. Role of Insurance Coverage in Contraceptive Use After Abortion. Biggs MA, Taylor D, Upadhyay UD. Obstet Gynecol; 2017 Dec 10; 130(6):1338-1346. PubMed ID: 29112661 [Abstract] [Full Text] [Related]
17. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK. Varney SJ, Guest JF. Pharmacoeconomics; 2004 Dec 10; 22(17):1141-51. PubMed ID: 15612832 [Abstract] [Full Text] [Related]
18. Impact of long-acting reversible contraception on return for repeat abortion. Rose SB, Lawton BA. Am J Obstet Gynecol; 2012 Jan 10; 206(1):37.e1-6. PubMed ID: 21944222 [Abstract] [Full Text] [Related]